Ipsen Pharma Biotech S.A.S.

Specialty Pharma Firm Auxilium Raises $41.25M In Initial Offering.
BIOWORLD Today; 11/3/2009; 900 words; ...Like most other biotech IPOs that have...own in the U.S. through a 97...Outside the U.S., the company...with Paris-based Ipsen SA, which has...except the U.S., Canada, Mexico...offering in the biotech industry this year...

Other News To Note.(BioTrove Inc)(DOR BioPharma Inc)(Vical Inc.)(M-G Inc.)
BIOWORLD Today; 9/9/2009; 1659 words; ...commercialize Ipsen's first-in-class...Debio 0931, with Ipsen having an option...Phase II trials. Ipsen will receive an...disclosed. Kane Biotech Inc., of Winnipeg...test the Kane's DispersinB biofilm...Bayer Schering Pharma AG, of Berlin...

Marketing Authorization Granted by KFDA for TMX-67, Chronic Management of Hyperuricemia in Patients with Gout.
Biotech Week; 7/29/2009; 921 words; ...and in the U.S. in February 2009 by Teijin Pharma's licensees in each area, Ipsen and Takeda Pharmaceuticals...Ltd., Teijin Pharma Limited, Therapy, Treatment, U.S. Food and Drug...was prepared by Biotech Week editors from...

BioSante Pharmaceuticals Announces Elestrin[TM] NDA Submission in Israel.
Women's Health Weekly; 7/9/2009; 1010 words; ...licensed from Antares Pharma, Inc. Also in...market in the U.S. for estrogen...pharmaceutical and biotech companies, including...compliance and pharma-covigilance...Pharmaceuticals, Ipsen, Astellas Pharma...Treatment, U.S. Food and Drug...

BIO 2009 Special Event: Meet with French Biotech Companies on May 18.
Cancer Weekly; 5/26/2009; 980 words; ...one of France's seven world-class...Development from IPSEN Ltd (see also Biotech Business). This...Manager, ERYTech Pharma Skuld-Tech: Genomics...exchange with major biotech business actors...America (Office of S&T), The...